A two-step model for development of non-insulin-dependent diabetes

The American Journal of Medicine

Volumn 90, Issue 1, 1991, Pages 229-235

  Saad, Mohammed F ^a   Knowler, William C ^a   Pettitt, David J ^a   Nelson, Robert G ^b   Charles, Marie A ^a   H Bennett, Peter ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b Department of Biostatistics and Epidemiology The Cleveland Clinic Foundation ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; FEMALE; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS FUNCTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ARIZONA; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, NON-INSULIN-DEPENDENT; FEMALE; HUMAN; INDIANS, NORTH AMERICAN; ISLETS OF LANGERHANS; LONGITUDINAL STUDIES; MALE; MODELS, BIOLOGICAL; PREVALENCE;

EID: 0025854677     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/0002-9343(91)90547-B     Document Type: Article

References (59)

1. Role of insulin resistance in human disease
2. The triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM
3. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus
4. Toward physiological understanding of glucose tolerance: minimal-model approach
5. Nonketotic diabetes mellitus: insulin deficiency or insulin resistance?
6. Non-insulin-dependent diabetes mellitus: interplay between B-cell inadequacy and insulin resistance
7. Beta-cell deficiency, insulin resistance, or both?
8. Type 2 diabetes or NIDDM: looking for a better name
9. Diabetes incidence and prevalence in Pima Indians: a 19-fold greater incidence than in Rochester, Minnesota
10. The natural history of impaired glucose tolerance in the Pima Indians
11. Diabetes mellitus
12. Diabetes incidence in Pima Indians: contributions of obesity and parental diabetes
13. Sequential changes in serum insulin concentration during development of noninsulin-dependent diabetes
14. Transient impaired glucose tolerance in the Pima Indians: is it significant?
15. Regression models and life-tables
16. In vivo insulin action is familial characteristic in nondiabetic Pima Indians
17. Unexplained hyperinsulinemia in normal and “prediabetic” Pima Indians compared with normal Caucasians: an example of racial differences in insulin secretion
18. Factors associated with the development of diabetes in the Micronesian population of Nauru
19. Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus
20. Serum immunoreactive insulin responses to a glucose load in Asian Indian and European type 2 (non-insulin-dependent) diabetic patients and control subjects
21. Impaired glucose tolerance, hyperinsulinemia, and hypertriglyceridemia in Australian aborigines from the desert
22. Insulin resistance in apparently healthy children
23. Plasma insulin response among Nauruans: prediction of deterioration in glucose tolerance over 6 years
24. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution
25. Association of elevated fasting C-peptide level and increased intraabdominal fat distribution with development of NIDDM in Japanese-American men
26. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in offspring of diabetic parents
27. Risk factors of type 2 (non-insulindependent) diabetes in Caucasian population
28. Relationship between degree of obesity and in vivo insulin action in man
29. Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians
30. Insulin resistance predicts the development of non-insulin-dependent diabetes mellitus in Pima Indians
31. Diminished insulin sensitivity and increased insulin response in nonobese, nondiabetic Mexican Americans
32. Changes in serum insulin are independently related to weight gain and worsening glucose tolerance in Pima Indians
33. Heterogeneity of insulin responses: phases leading to type 2 (non-insulin-dependent) diabetes mellitus in the rhesus monkey
34. Distribution of in vivo insulin action in Pima Indians as mixture of three normal distributions
35. Decreased insulin sensitivity in offspring whose parents both have type 2 diabetes
36. What is inherited in NIDD?
37. Early metabolic defects in persons at increased risk for non-insulin-dependent diabetes mellitus
38. Insulin resistance and hypertriglyceridemia in nondiabetic relatives of patients with noninsulin-dependent diabetes mellitus
39. Insulin insensitivity in offspring of parents with type 2 diabetes mellitus
40. Increased insulin concentrations in nondiabetic offspring of diabetic parents
41. Mechanisms of insulin resistance in aging
42. Effects of body composition on insulin sensitivity
43. Epidemiology, obesity, and non-insulin-dependent diabetes mellitus
44. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects
45. Insulin receptor kinase in human skeletal muscle from obese subjects with and without non-insulin-dependent diabetes
46. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man
47. Effect of past and concurrent body mass index on prevalence of glucose intolerance and type 2 (non-insulin-dependent) diabetes and on insulin response: the Israel study of glucose intolerance, obesity and hypertension
48. Non-insulin-dependent diabetes (NIDDM) risk in persons with impaired glucose tolerance (IGT): role of insulin, obesity, and fat patterning
49. Insulin secretion in diabetes mellitus
50. Disproportionately elevated proinsulin in Pima Indians with non-insulin-dependent diabetes mellitus
51. Hyperglycemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes
52. Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy
53. Type II diabetes, glucose “non-sense”, and islet desensitization
54. Glucose toxicity
55. Islet mass and function in diabetes and transplantation
56. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes
57. Hyperproinsulinemia and amyloid in NIDDM: clues to etiology of islet β-cell dysfunction?
58. Islet amyloid formed from diabetes associated peptide may be pathogenic in type-2 diabetes
59. Islet amyloid and islet amyloid polypeptide in diabetic and non-diabetic Pima Indians